Correlation Between GlaxoSmithKline PLC and Invesco SP
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Invesco SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Invesco SP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Invesco SP Emerging, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Invesco SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Invesco SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Invesco SP.
Diversification Opportunities for GlaxoSmithKline PLC and Invesco SP
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between GlaxoSmithKline and Invesco is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Invesco SP Emerging in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco SP Emerging and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Invesco SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco SP Emerging has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Invesco SP go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Invesco SP
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Invesco SP. In addition to that, GlaxoSmithKline PLC is 2.1 times more volatile than Invesco SP Emerging. It trades about -0.3 of its total potential returns per unit of risk. Invesco SP Emerging is currently generating about -0.15 per unit of volatility. If you would invest 2,513 in Invesco SP Emerging on August 25, 2024 and sell it today you would lose (55.00) from holding Invesco SP Emerging or give up 2.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Invesco SP Emerging
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
Invesco SP Emerging |
GlaxoSmithKline PLC and Invesco SP Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and Invesco SP
The main advantage of trading using opposite GlaxoSmithKline PLC and Invesco SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Invesco SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco SP will offset losses from the drop in Invesco SP's long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Invesco SP vs. Invesco SP International | Invesco SP vs. SPDR SP Emerging | Invesco SP vs. Invesco SP MidCap | Invesco SP vs. Invesco DWA Emerging |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |